{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:56:41Z","timestamp":1790791001336,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001049"],"award-info":[{"award-number":["MOH-001049"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001488"],"award-info":[{"award-number":["MOH-001488"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.yexmp.2025.105009","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:16:55Z","timestamp":1763695015000},"page":"105009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Persistent renin-angiotensin system and inflammatory dysregulation following COVID-19 impairs ischemic stroke recovery"],"prefix":"10.1016","volume":"144","author":[{"given":"Amy May Lin","family":"Quek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ooiean","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hea","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette Guek Cheng","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle Chuen Hian","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chee Seong","family":"Seet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.yexmp.2025.105009_bb0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1113\/expphysiol.2007.040345","article-title":"Genetically altered animal models for mas and angiotensin-(1-7)","volume":"93","author":"Alenina","year":"2008","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/dom.12571","article-title":"Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels","volume":"18","author":"Blauw","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105009_bb0020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/db16-1318","article-title":"Neprilysin is required for angiotensin-(1-7)\u2019s ability to enhance insulin secretion via its proteolytic activity to generate angiotensin-(1-2)","volume":"66","author":"Brar","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-022-00409-w","article-title":"Current challenges and best practices for cell-free long RNA biomarker discovery","volume":"10","author":"Cabus","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.yexmp.2025.105009_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847809","article-title":"Plasma angiotensin II is increased in critical coronavirus disease 2019","volume":"9","author":"Camargo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20242168","article-title":"Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients","volume":"139","author":"Chappell","year":"2025","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.yexmp.2025.105009_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.omtm.2022.07.003","article-title":"Decrease in angiotensin-converting enzyme activity but not concentration in plasma\/lungs in COVID-19 patients offers clues for diagnosis\/treatment","volume":"26","author":"Daniell","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yexmp.2025.105009_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1073924","article-title":"Large vessel occlusion stroke outcomes in diabetic vs. non-diabetic patients with acute stress hyperglycemia","volume":"17","author":"Duan","year":"2023","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.yexmp.2025.105009_bb0065","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/STROKEAHA.118.022888","article-title":"Extracellular vimentin\/VWF (von Willebrand factor) interaction contributes to VWF string formation and stroke pathology","volume":"49","author":"Fasipe","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.yexmp.2025.105009_bb0080","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A8673","article-title":"Effect of SARS-CoV2 infection on endovascular Thrombectomy outcomes - data from the Florida stroke registry","author":"Fountain","year":"2025","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.yexmp.2025.105009_bb0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.hrthm.2021.01.032","article-title":"Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients","volume":"18","author":"Harpaz","year":"2021","journal-title":"Heart Rhythm."},{"issue":"2","key":"10.1016\/j.yexmp.2025.105009_bb0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2004.07.086","article-title":"Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats","volume":"369","author":"Harvey","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"40","key":"10.1016\/j.yexmp.2025.105009_bb0095","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.RA120.014183","article-title":"Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice","volume":"295","author":"Jha","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yexmp.2025.105009_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5607\/en.2017.26.4.195","article-title":"NOX inhibitors - a promising avenue for ischemic stroke","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105009_bb0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.yexmp.2025.105009_bb0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/bioinformatics\/btt087","article-title":"EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments","volume":"29","author":"Leng","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yexmp.2025.105009_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105009_bb0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cmet.2022.01.008","article-title":"Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry","volume":"34","author":"Li","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.yexmp.2025.105009_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fncel.2018.00215","article-title":"Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma+TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10)","volume":"12","author":"Lively","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.yexmp.2025.105009_bb0140","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00415-021-10837-7","article-title":"Ischemic stroke associated with COVID-19: a systematic review and meta-analysis","volume":"269","author":"Luo","year":"2022","journal-title":"J. Neurol."},{"issue":"15","key":"10.1016\/j.yexmp.2025.105009_bb0150","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1073\/pnas.1533187100","article-title":"Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes","volume":"100","author":"Menet","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.yexmp.2025.105009_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.2730","article-title":"Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza","volume":"77","author":"Merkler","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.yexmp.2025.105009_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310094","article-title":"The role of midkine in health and disease","volume":"14","author":"Neumaier","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2025.105009_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625732","article-title":"Expression of ACE2, soluble ACE2, angiotensin I, angiotensin II and angiotensin-(1-7) is modulated in COVID-19 patients","volume":"12","author":"Osman","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105009_bb0170","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03730-2020","article-title":"Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences","volume":"57","author":"Patel","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.yexmp.2025.105009_bb0175","article-title":"Hybrid immunity augments cross-variant protection against COVID-19 among immunocompromised individuals","volume":"89","author":"Quek","year":"2024","journal-title":"J. Inf. Secur."},{"issue":"2","key":"10.1016\/j.yexmp.2025.105009_bb0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/heartjnl-2022-321492","article-title":"Cardiovascular disease and mortality sequelae of COVID-19 in the UK biobank","volume":"109","author":"Raisi-Estabragh","year":"2022","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.yexmp.2025.105009_bb0185","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ajpath.2021.04.010","article-title":"ACE2 Down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients","volume":"191","author":"Ramos","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105009_bb0190","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","article-title":"Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function","volume":"52","author":"Rentzsch","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"12","key":"10.1016\/j.yexmp.2025.105009_bb0215","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/qjmed\/hcae136","article-title":"Plasma NOTCH3 and the risk of cardiovascular recurrence in patients with ischemic stroke","volume":"117","author":"Seet","year":"2024","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (Prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.yexmp.2025.105009_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/srep28293","article-title":"Extracellular vimentin is a novel axonal growth facilitator for functional recovery in spinal cord-injured mice","volume":"6","author":"Shigyo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2025.105009_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113201","article-title":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19","volume":"152","author":"Silva","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.yexmp.2025.105009_bb0235","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/HYPERTENSIONAHA.120.15291","article-title":"ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic","volume":"76","author":"South","year":"2020","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.yexmp.2025.105009_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70098","article-title":"Elevated soluble ACE2 activity in children and adults after SARS-CoV-2 exposure irrespective of laboratory-confirmed infection","volume":"96","author":"Stich","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.123.043899","article-title":"Effect of asymptomatic and symptomatic COVID-19 on acute ischemic stroke revascularization outcomes","volume":"55","author":"Strambo","year":"2024","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.yexmp.2025.105009_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115911","article-title":"ADAM-17 activity and its relation to ACE2: implications for severe COVID-19","volume":"25","author":"Sun","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yexmp.2025.105009_bb0265","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cmi.2023.12.024","article-title":"Biomarkers of early SARS-CoV-2 infection before the onset of respiratory symptoms","volume":"30","author":"Teng","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.47102\/annals-acadmedsg.2020105","article-title":"Long-term outcomes of ischaemic stroke patients with diabetes in a multi-ethnic cohort in Singapore","volume":"50","author":"The","year":"2021","journal-title":"Ann. Acad. Med. Singap."},{"issue":"3","key":"10.1016\/j.yexmp.2025.105009_bb0285","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00114-2021","article-title":"Increased circulating levels of angiotensin-(1\u20137) in severely ill COVID-19 patients","volume":"7","author":"Valle Martins","year":"2021","journal-title":"ERJ Open Res."},{"issue":"1 Pt 1","key":"10.1016\/j.yexmp.2025.105009_bb0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.HYP.30.1.42","article-title":"Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo","volume":"30","author":"van Kats","year":"1997","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.yexmp.2025.105009_bb0300","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4155\/fmc-2019-0218","article-title":"Mechanisms of ebselen as a therapeutic and its pharmacology applications","volume":"12","author":"Wang","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.yexmp.2025.105009_bb0305","article-title":"ACE2 shedding and the role in COVID-19","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.yexmp.2025.105009_bb0310","doi-asserted-by":"crossref","DOI":"10.2196\/29544","article-title":"Uncovering clinical risk factors and predicting severe COVID-19 cases using UK biobank data: machine learning approach","volume":"7","author":"Wong","year":"2021","journal-title":"JMIR Public Health Surveill."},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0315","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","article-title":"Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients","volume":"24","author":"Wu","year":"2020","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.yexmp.2025.105009_bb0330","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.yexmp.2025.105009_bb0340","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/STROKEAHA.120.030335","article-title":"SARS-CoV-2 and stroke in a New York healthcare system","volume":"51","author":"Yaghi","year":"2020","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.yexmp.2025.105009_bb0350","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","article-title":"Next generation plasma proteome profiling to monitor health and disease","volume":"12","author":"Zhong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2025.105009_bb0365","article-title":"Crosstalk between the oxidative stress and glia cells after stroke: from mechanism to therapies","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480025000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:34:28Z","timestamp":1782952468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480025000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S0014480025000590"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.105009","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent renin-angiotensin system and inflammatory dysregulation following COVID-19 impairs ischemic stroke recovery","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2025.105009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105009"}}